Strumento inattivo

Azioni Dendreon Corporation Nasdaq

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

La stratégie de Valeant saluée en Bourse	23/02/15
Endo : Drugmaker Valeant close to buying Salix - source	20/02/15
Dendreon : Valeant secures financing for potential Salix bid: Bloomberg	12/02/15
Dendreon : Valeant to buy Dendreon's prostate cancer vaccine Provenge	30/01/15

Settore

	Variaz. 1 gen.	Capi.
IQVIA HOLDINGS INC.	+1,51%	42,75 Mrd
LONZA GROUP AG	+49,22%	41,61 Mrd
MODERNA, INC.	+8,57%	41,34 Mrd
CELLTRION, INC.	-12,36%	26,59 Mrd
ICON PUBLIC LIMITED COMPANY	+8,92%	25,49 Mrd
ALNYLAM PHARMACEUTICALS, INC.	-25,13%	18,12 Mrd
MEDPACE HOLDINGS, INC.	+29,17%	12,24 Mrd
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3,12%	11,76 Mrd
UNITED THERAPEUTICS CORPORATION	+6,35%	11 Mrd